Southern Pain & Anesthesia Consultants v. RF Medical Devices, Inc. , 439 F. App'x 285 ( 2011 )


Menu:
  •      Case: 10-30634     Document: 00511515726          Page: 1    Date Filed: 06/21/2011
    IN THE UNITED STATES COURT OF APPEALS
    FOR THE FIFTH CIRCUIT  United States Court of Appeals
    Fifth Circuit
    FILED
    June 21, 2011
    No. 10-30634                         Lyle W. Cayce
    Clerk
    SOUTHERN PAIN & ANESTHESIA CONSULTANTS, LIMITED LIABILITY
    CORPORATION; PAUL JOSEPH HUBBELL, III,
    Plaintiffs - Appellants
    v.
    RF MEDICAL DEVICES, INCORPORATED; MERCURY MEDICAL
    PRODUCTS, INCORPORATED, doing business as Precision Medical
    Engineering, Incorporated; NEUROTHERM, INCORPORATED; GENERAL
    STAR INDEMNITY COMPANY; TYCO HEALTHCARE GROUP LIMITED
    PARTNERSHIP; RADIONICS, INCORPORATED; VALLEYLAB,
    INCORPORATED; NOETIC SPECIALTY INSURANCE COMPANY,
    Defendants - Appellees
    Appeal from the United States District Court
    for the Middle District of Louisiana
    USDC No. 3:08-CV-827
    Before JONES, Chief Judge, and BENAVIDES and STEWART, Circuit Judges.
    PER CURIAM:*
    *
    Pursuant to 5TH CIR . R. 47.5, the court has determined that this opinion should not
    be published and is not precedent except under the limited circumstances set forth in 5TH CIR .
    R. 47.5.4.
    Case: 10-30634    Document: 00511515726      Page: 2   Date Filed: 06/21/2011
    No. 10-30634
    Southern Pain & Anesthesia Consultants, LLC and Dr. Paul Hubbell
    (“Plaintiffs”) appeal the district court’s grant of summary judgment for the
    defendants in this case, a group of medical device manufacturers and their
    insurers. The suit arises from a failed annuloplasty procedure that Dr. Hubbell
    performed on Toni Peavy in February 2004. The procedure used the defendants’
    medical product “discTRODE” and resulted in significant injury to Peavy. Peavy
    subsequently brought a state court action against Dr. Hubbell and all of the
    defendants in this case, alleging medical malpractice and product defect claims,
    respectively. In December 2008, while Peavy’s suit was pending, the Plaintiffs
    filed the underlying suit seeking indemnification and tort damages. The district
    court granted judgment for the defendants after concluding that the Plaintiffs’
    tort claims had prescribed under Louisiana law.
    We review the district court’s grant of summary judgment de novo. Holt
    v. State Farm Fire & Cas. Co., 
    627 F.3d 188
    , 191 (5th Cir. 2010). On appeal, the
    Plaintiffs’ sole argument is that the district court erred in concluding that their
    tort claims had prescribed. The Plaintiffs argue that because they alleged the
    same tort claims as Peavy did in her suit and both suits arise from the 2004
    procedure, Peavy and the Plaintiffs share an “identity of interest.” As a result,
    Plaintiffs assert, Peavy’s suit interrupted prescription and their tort claims did
    not begin to run until Peavy’s suit was dismissed in March 2009.
    “When it is clear on the face of a plaintiff's petition that prescription has
    run, the plaintiff bears the burden of showing why the claim has not prescribed.”
    Williams v. Sewerage & Water Bd. of New Orleans, 
    611 So.2d 1383
    , 1386 (La.
    1993). Louisiana has a one-year prescription period for tort (delictual) claims,
    which “commences to run from the day injury or damage is sustained.” L A. C IV.
    C ODE art. 3492. The district court determined that the Plaintiffs became aware
    of the facts giving rise to their tort claims by December 6, 2007, a finding the
    Plaintiffs do not challenge. The Plaintiffs filed their suit over a year later, on
    2
    Case: 10-30634    Document: 00511515726      Page: 3    Date Filed: 06/21/2011
    No. 10-30634
    December 19, 2008, and thus their tort claims were prescribed on their face.
    Below, the Plaintiffs attempted to carry their burden of proof by arguing that
    Peavy’s suit had interrupted prescription, an argument they renew here.
    The Louisiana Supreme Court has stated that where a “subsequent
    claimant is a different person than the original plaintiff”—as here—“then to
    interrupt prescription [1] the first suit must . . . be based upon the same factual
    occurrence as is the subsequent claim by amended petition or intervention;” and
    “[2] the subsequent claimant must also be closely connected in relationship and
    identity of interest with the original plaintiff.” Allstate Ins. Co. v. Theriot, 
    376 So. 2d 950
    , 954 (La. 1979), abrogated on other grounds by Stenson v. City of
    Oberlin, — So. 3d —, 
    2011 WL 893394
     (La. Mar. 15, 2011). The Plaintiffs argue
    that their tort claims meet the Theriot “test” for interruption by a previous suit.
    We do not agree. To begin with, the Plaintiffs did not bring their tort
    claims “by amended petition or intervention” in Peavy’s suit; they inexplicably
    brought them in a wholly separate action four years after Peavy’s original
    pleading. Second, the Plaintiffs have not shown that they share a sufficiently
    close “relationship and identity of interest” with Peavy. Such a relationship
    exists between a subroger and subrogee; a deceased defendant and his survivors;
    and an employer’s insurer and employee. See Theriot, 
    376 So. 2d at 954
     (listing
    cases). Louisiana courts have also found that where a tortfeasor-defendant files
    a third-party demand and the original plaintiff subsequently amends his petition
    to sue the same third party, the third-party demand may interrupt prescription
    on the plaintiff’s new claim. See 
    id.
     at 954 n.4 (citing Carona v. Radwin, 
    195 So. 2d 465
     (La. Ct. App. 1967)). As the district court found, the relationship between
    Peavy and the Plaintiffs does not comport with any that the Louisiana courts
    have recognized as permitting interruption.
    Similarly, the Plaintiffs do not “share a single cause of action” with Peavy
    that would warrant interruption. “[W]hen several parties share a single cause
    3
    Case: 10-30634    Document: 00511515726       Page: 4   Date Filed: 06/21/2011
    No. 10-30634
    of action (as through partial subrogation), suit by one interrupts prescription as
    to all.” Louviere v. Shell Oil Co., 
    440 So.2d 93
    , 96 (La. 1983). “However, when
    a suit by a second party states a different cause of action than the suit by the
    first party, although each cause of action is based in part on common facts, the
    first suit does not interrupt prescription as to the subsequent cause of action.”
    
    Id.
     For purposes of this principle, a “cause of action consists of the material facts
    which form the basis of the right claimed by the party bringing the action.” 
    Id. at 95
    . In their complaint, the Plaintiffs alleged a right to recover for economic
    damages incurred as a result of Peavy’s medical malpractice claims against
    them. This alleged cause of action is not identical to Peavy’s right to recover for
    physical injuries resulting from the 2004 procedure.
    For the above reasons, the judgment of the district court is AFFIRMED.
    4
    

Document Info

Docket Number: 10-30634

Citation Numbers: 439 F. App'x 285

Judges: Jones, Benavides, Stewart

Filed Date: 6/22/2011

Precedential Status: Non-Precedential

Modified Date: 11/5/2024